Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$32.49 USD
+0.25 (0.78%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $32.51 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$32.49 USD
+0.25 (0.78%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $32.51 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
Surgery Partners (SGRY) Q4 Earnings Lag Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of -16.67% and 2.60%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a Top Momentum Pick? Why Surgery Partners (SGRY) is a Great Choice
by Zacks Equity Research
Does Surgery Partners (SGRY) have what it takes to be a top stock pick for momentum investors? Let's find out.
Zendesk (ZEN), Surgery Partners (SGRY) and Tesla (TSLA) Are Aggressive Growth Stocks
by Brian Bolan
A look a three names on your aggressive growth stock radar screen.
Moving Average Crossover Alert: Surgery Partners
by Zacks Equity Research
Surgery Partners is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Will Surgery Partners Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Surgery Partners.
Surgery Partners (SGRY) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of 0.00% and 0.04%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Surgery Partners (SGRY) Q3 Earnings Expected to Decline
by Zacks Equity Research
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surgery Partners (SGRY) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of -70.59% and -0.93%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Surgery Partners (SGRY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Surgery Partners (SGRY) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of -40.00% and 0.25%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Surgery Partners (SGRY) Q1 Earnings Expected to Decline
by Zacks Equity Research
Surgery Partners (SGRY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Cheap Small Cap Stocks with Big Growth
by Tracey Ryniec
Stocks are selling off. Are you ready to look for some bargains?
Surgery Partners (SGRY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Surgery Partners (SGRY) delivered earnings and revenue surprises of -20.00% and 2.96%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for September 28th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: